D14 - Accelerating Cell Therapies in Type 1 Diabetes

Sunday, August 10, 2025

11:00 AM - 11:45 AM MST

CE/CME Hours: .75 CE

Universal Activity Number (Live): JA4008258-0000-25-157-L01-P

Project Accelerate Cell Therapies, or "Project ACT," is a Breakthrough T1D initiative to dramatically speed cell therapy as T1D cures through coordinated efforts to simultaneously advance research, development, regulatory affairs, access, and adoption. Join this session to understand the current state of cell therapies in T1D care, explore Breakthrough T1D's strategy to accelerate cell therapies, and acquire knowledge of currently recruiting cell therapies.

Disclosure(s):

Anastasia Albanese-O'Neill, PhD, APRN, CDCES: No financial relationships to disclose

Sanjoy Dutta, PhD: No financial relationships to disclose

Co-Presenter(s)

Anastasia Albanese-O'Neill, PhD, APRN, CDCES (she/her/hers)

Vice President, Medical Affairs
Breakthrough T1D

Disclosure(s): No financial relationships to disclose

Primary Presenter(s)

Sanjoy Dutta, PhD

Chief Scientific Officer
Breakthrough T1D (formerly JDRF)

Disclosure(s): No financial relationships to disclose